Immunogen | IMGN - Passifs Courants



Passifs Courants Changement Date
AbbVie USD 41.64B 458M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Amgen USD 25.5B 547M 2026-06
Astellas Pharma JPY 1.23T 16.36B 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Exelixis USD 361.93M 9.05M 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 32.65B 1.7B 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 30.01B 1.66B 2026-03